Response of blood platelets to β-glucan from Saccharomyces cerevisiae

Platelets

Volumn 21, Issue 1, 2010, Pages 37-43

  Saluk Juszczak, Joanna ^a   Królewska, Karolina ^a   Wachowicz, Barbara ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

glucan; Aggregation; Blood platelets; Platelet activation

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; BETA GLUCAN; COLLAGEN; CYTOCHROME C; SUPEROXIDE; THROMBIN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEGRANULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATORY DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADULT; BETA-GLUCANS; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PLATELET ACTIVATION; SACCHAROMYCES CEREVISIAE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

SACCHAROMYCES CEREVISIAE;

EID: 75449110556     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537100903359306     Document Type: Article

References (46)

1. Kroll MH, Schafer AJ. The analysis of ligand-receptor interaction in platelet activation. Immunopharmacol 1995; 29:31-35.
2. Shapiro AD. Platelet function disorders. Haemophilia 2000;6:120-128.
3. Levy-Toledano S. Platelet signal transduction pathways: Could we organize them into a hierarchy? Haemostasis 1999;29:4-15.
4. Sadula J, Kogan G, Kacurkova M, Machova E. Microbial (1→3)-β-D- glucans, their preparation, physico-chemical characterization and immunomodulatory activity. Carbohydrate Polymers 1999;38:247-253.
5. Akramienė D, Anatolijus K, Didžiapetrienė J, Kėvelaitis E. Effects ofβ-glucans on the immune system. Medicina 2007; 43:597-606.
6. Pelizon AC, Kaneno R, Soares AM, Meira DA, Satori A. Immunomodulatory activities associated with beta-glucan derived from Saccharomyces cerevisiae. Physiol Res 2005; 54:557-564.
7. Kim GY, Choi GS, Lee SH, Park YM. Acidic polysaccharide isolated from Phellinus linteus enhances through the upregulation of nitric oxide and tumor necrosis factor-alpha from peritoneal macrophages. J Ethnopharamacol 2004;95:69-76.
8. Wachowicz B, Kustron J. Effect of cisplatin on lipid peroxidation in pig blood platelets. Cytobios 1992;70:41-47.
9. Walkowiak B, Michalak E, Koziolkiewicz W, Cierniewski CS. Rapid photometric metod for estimation of platelet count in blood plasma or platelet suspension. Thromb Res 1989; 56:763-766.
10. Wachowicz B. Adenine nucleotides in thrombocytes of birds. Cell Biochem Function 1984;2:167-170.
11. Olas B, Zbikowska HM, Wachowicz B, Krajewski T, Buczyń ski A, Magnuszewska A. Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim Polon 1999;46:961-966.
12. Jahn B, Hansch GM. Oxygen radical generation in human platelets: Dependence of 12-lipoxygenase activity and on the glutathione cycle. Int Arch Allergy Immunol 1990;93:73-79.
13. Nowak P, Wachowicz B. Peroxynitrite-mediated modification of fibrinogen affects platelet aggregation and adhesion. Platelets 2002;13:293-299.
14. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurment of protein using bicinchonic acid. Anal Biochem 1985:76-85.
15. Fukami MH, Holmsen H, Salganicoff L. Adenine nucleotide metabolism of blood platelets. IX. Time course of secretion and changes in energy metabolism in thrombin-treated platelets. Biochim Biophys Acta 1986;4:633-643.
16. Wróblewski F, La Due J. Lactic dehydrogenase activity in blood. Proc Soc Exp Med 1955;210:210-215.
17. Danese Silvio MD, Fiocchi Claudio MD. Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications. Am J Gastroenterol 2004;99:938-945.
18. Page CP. Platelets as inflammatory cells. Immunopharmacol 1989;17:51-59.
19. Daniel G, Remick MD. Pathophysiology of Sepsis. Am J Pathol 2007;170:1435-1444.
20. Kleinpell R. Advances in treating patients with severe sepsis. Crit Car Nurs 2003;23:16-29.
21. Laroche C, Michaud P. New developments and prospective applications for β (1,3) glucans. Rec Pat Biotechnol 2007; 1:59-73.
22. Gordon D, Brown G. Fungal β-glucans and mammalian immunity. Immunity 2003;1:311-315.
23. Kogan G, Stasko A, Bauerova K, Palonka M. Antioxidant properties of yeast (1→3)-β-D-glucan studied by electron paramagnetic resonance spectroscopy and its activity in the adjuvant arthritis. Carbohydrate Polymers 2005;61:18-28.
24. Hong F, Hansen D, Yan J, Allendorf DJ, Baran JT. B-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res 2003;63:9023-9031.
25. Hofer M, Pospiśil M. Glucan as stimulator of hepatopoesis in normal and gamma-irradiated mice. Int J Immunopharmacol 1997;19:607-609.
26. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 2001;6:36-37.
27. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SY, Gordon S. Dectin-1 as a major beta-glucan receptor on macrophages. J Exp Med 2002;196:407-412.
28. Yadav M, Schorey JS. The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 2006;108:3168-3176.
29. Adam C, Kauf W, Scott M, Bowditch RD. Recognition of fibronectin by the platelet integrin αIIbβ3 involves an extended interface with multiple electrostatic interactions. Biochemistry 2001;40:9159-9166.
30. Ważna E. Platelet-mediated regulation of immunity. Post Hig Med Dośw 2006;60:265-277.
31. Tsiapali E, Whaley S, Kalbfleisch J, Ensley HE, Browder IW, Williams DL. Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Rad Biol Med 2001;30:393-402.
32. Kogan G, Stasko A, Bauerova K, Palonka M. Antioxidant properties of yeast (1→3)-β-D-glucan studied by electron paramagnetic resonance spectroscopy and its activity in the adjuvant arthritis. Carbohydrate Polymers 2005;61:18-28.
33. Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, et al. A phase II multicenter double-blind randomized placebo-controlled study of three dosage of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch Surg 1994;129:1204-1210.
34. Gawaz M, Langer H, May E. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378-3384.
35. Zarbock A, Polanowska-Grabowska R, Ley M. Plateletneutrophil- interactions: Linking hemostasis and inflammation. Blood 2007;21:99-111.
36. Denese S, Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: Mechanisms and implications for human disease. Crit Rev Immunol 2005;25:103-121.
37. Lim HS, Blann AD, Lip GYH. Soluble CD ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus. Relationship to cardiovascular disease and risk factor intervention. Circulation 2004;9:2524-2528.
38. Palma AS, Feizi T, Zhang Y, Stoll MS, Lawson AM, Gordon D Brown. Ligands for the β-glucan receptor, dectin-1, assigned using, designer, microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polisaccharydes. J Biol Chem 2006;81:5771-5779.
39. Yadav M, Schorey JS. The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 2006;108:3168-3176.
40. Blair P, Rex S, Vitseva O, Beaulieu L, Tanriverdi K, Chakrabarti S, Hayashi C, Genco CA, Iafrati M, Freedman JE. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res 2009;3:346-354.
41. Ryningen A, Holmsen H.Biochemistry of platelet activation. In: Gundu H, Rao R, editors. Platelet physiology and pharmacology. Norwell: Kluwer Academic Publishers; 1999. p 1.
42. Frelinger AR, Furman MJ, Linden MD, Youfu L, Fox ML, Michelson AD. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway. Circulation 2006;113:2888-2896.
43. Kim C, Kim JY, Kim JH. Cytosolic phospolipase A(2), lipoxygenase metabolites, and reactive oxygen species. BMB Rep 2008;31:555-559.
44. Wachowicz B, Olas B, Ż bikowska HM, Buczyń ski A. Generation of reactive oxygen species in blond platelets. Platelets 2002;13:175-182.
45. Olas B, Wachowicz B. Role of reactive nitrogen species in blood platelet functions. Platelets 2007;8:555-565.
46. Silke CJ, Rohn S, Kroch LW, Fleischer L, Kurz T. In vitro potential antioxidant activity of β-(1,3)(1,6)-D-glucan and protein fractions from Saccharomyces cerevisiae cell walls. J Agric Food Chem 2007;55:4710-4716.